Regeneron Pharmaceuticals Earnings Per Share

REGN -- USA Stock  

Earning Report: November 5, 2019  

Regeneron Pharmaceuticals earnings-per-share fundamental analysis lookup allows you to check this and other indicators for Regeneron Pharmaceuticals or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Regeneron Pharmaceuticals Earnings Per Share Analysis

Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share 
Average Shares 
More About Earnings Per Share | All Equity Analysis
Regeneron Pharmaceuticals Earnings Per Share  =
Regeneron Pharmaceuticals ValuationFundamentalsBuy or Sell

Regeneron Pharmaceuticals Earnings Per Share Over Time Pattern

 Regeneron Pharmaceuticals Earnings per Diluted Share 

About Earnings Per Share

Earnings per Share is one of the most important measures of the current share price of a firm, and is used by investors to determine the company overall profitability; especially when it is compared to the EPS of similar companies.
Compare to competition

Regeneron Pharmaceuticals Earnings Per Share Assessment

Shareholders Equity
According to company disclosure Regeneron Pharmaceuticals has Earnings Per Share of 18.0 times. This is 115.05% higher than that of the Healthcare sector, and 475.78% lower than that of Biotechnology industry, The Earnings Per Share for all stocks is 476.92% lower than the firm.

Regeneron Pharmaceuticals Earnings Per Share Peer Comparison

Regeneron Pharmaceuticals is rated second in earnings per share category among related companies.

Regeneron Pharmaceuticals current financial ratios